Parent Terms |
Term With Siblings |
Child Terms |
|
(1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol
(1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol hydrochloride
(2S)-2-(4-\{[(1R,2S)-2-hydroxycyclopentyl]methyl\}phenyl)propanoic acid
(S)-fenfluramine hydrochloride
1-(3-(trifluoromethyl)phenyl)piperazine +
1-(3-chlorophenyl)piperazine
2-\{[(2E)-3-iodoprop-2-en-1-yl](propyl)amino\}tetralin-7-ol
2-\{[(2E)-3-iodoprop-2-en-1-yl](propyl)amino\}tetralin-7-ol maleate
3-aza-A-homocholest-4a-en-4-one
4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline +
4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline dimaleate
4-(methylamino)antipyrine
4-fluoro-N-\{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl\}benzamide
4-fluoro-N-\{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl\}benzamide hydrochloride
5-methyltryptamine hydrochloride
5-nonyloxytryptamine oxalate
6,8-dimethyl-6,7-didehydroergolin-6-ium
8-epi-prostaglandin F2alpha +
9-deacetoxyfumigaclavine C
alpha-methylnoradrenaline
bromfenac sodium salt sesquihydrate
carbocyclic thromboxane A2 +
cariprazine hydrochloride
carmoxirole hydrochloride
chlorprothixene hydrochloride
Delta(9)-tetrahydrocannabinol +
dihydro-alpha-ergocryptine +
dihydro-beta-ergocryptine +
dihydrochanoclavine-I aldehyde
dihydrochanoclavine-I aldehyde(1+)
dihydroergotamine + Ergotamine in which a single bond replaces the double bond between positions 9 and 10. A semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine, it is used (as the methanesulfonic or tartaric acid salts) for the treatment of migraine and orthostatic hypotension.
dihydroergotamine mesylate
dihydroergotamine tartrate
dopamine receptor D1 agonist +
eprinomectin component B1a +
eprinomectin component B1b +
fenfluramine hydrochloride +
leucascandrolide A congener
lorcaserin hydrochloride +
lorcaserin hydrochloride hemihydrate
loxoprofen sodium hydrate
lysergic acid diethylamide +
N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol
N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide
N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide
N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol
N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol
N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide
N-methylquipazine dimaleate
O-(chloroacetylcarbamoyl)fumagillol
oxymetazoline hydrochloride
P(1),P(5)-bis(5'-adenosyl) pentaphosphate
P(1),P(6)-bis(5'-adenosyl)hexaphosphate
phenazopyridine hydrochloride
pramipexole hydrochloride
pramipexole hydrochloride anhydrous +
statin (semi-synthetic) +
tetrahydrozoline hydrochloride
vortioxetine hydrobromide
|
|
|
Synonyms |
Exact Synonyms: |
(10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
|
Related Synonyms: |
5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
;
9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
;
9,10-dihydroergotamine
;
Formula=C33H37N5O5
;
InChI=1S/C33H37N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39)/t21-,23-,25-,26+,27+,32-,33+/m1/s1
;
InChIKey=LUZRJRNZXALNLM-JGRZULCMSA-N
;
SMILES=[H][C@@]12Cc3c[nH]c4cccc(c34)[C@@]1([H])C[C@H](CN2C)C(=O)N[C@]1(C)O[C@]2(O)N([C@@H](Cc3ccccc3)C(=O)N3CCC[C@@]23[H])C1=O
;
dihidroergotamina
;
dihydroergotaminum
|
Alternate IDs: |
CHEBI:4826
;
CHEBI:658566
|
Xrefs: |
Beilstein:78887
;
CAS:511-12-6
;
DrugBank:DB00320
;
Drug_Central:888
;
KEGG:C07798
;
KEGG:D07837
;
KNApSAcK:C00001724
;
LINCS:LSM-3619
|
Xref Mesh: |
MESH:D004087
|
Xrefs: |
PMID:10954953
;
PMID:20132337
;
PMID:8145914
;
Wikipedia:Dihydroergotamine |
|